FI882340A0 - Paratropisk molekyl riktad mot human-gangliocid gd2. - Google Patents

Paratropisk molekyl riktad mot human-gangliocid gd2.

Info

Publication number: FI882340A0
Authority: FI; Finland
Prior art keywords: riktad; paratropisk; molekyl; gangliocid; mot
Prior art date: 1986-09-19

Application number

FI882340A

Other languages

English (en)

Other versions

FI882340L (fi

Inventor

David A Cheresh

Ralph A Reisfeld

Original Assignee

Scripps Clinic Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-09-19

Filing date

1988-05-18

Publication date

1988-05-18

1988-05-18 Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res

1988-05-18 Publication of FI882340A0 publication Critical patent/FI882340A0/fi

1988-05-18 Publication of FI882340L publication Critical patent/FI882340L/fi

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Chemical & Material Sciences (AREA)
Oncology (AREA)
Cell Biology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Hospice & Palliative Care (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI882340A 1986-09-19 1988-05-18 Paratropisk molekyl riktad mot human-gangliocid gd2. FI882340L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90922586A	1986-09-19	1986-09-19
PCT/US1987/002419 WO1988002117A1 (en)	1986-09-19	1987-09-18	Monoclonal paratopic molecule directed to human ganglioside gd2

Publications (2)

Publication Number	Publication Date
FI882340A0 true FI882340A0 (fi)	1988-05-18
FI882340L FI882340L (fi)	1988-05-18

Family

ID=25426845

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI882340A FI882340L (fi)	1986-09-19	1988-05-18	Paratropisk molekyl riktad mot human-gangliocid gd2.

Country Status (5)

Country	Link
EP (1)	EP0282581A4 (fi)
AU (1)	AU617652B2 (fi)
DK (1)	DK271488D0 (fi)
FI (1)	FI882340L (fi)
WO (1)	WO1988002117A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4844893A (en) *	1986-10-07	1989-07-04	Scripps Clinic And Research Foundation	EX vivo effector cell activation for target cell killing
DE3909799A1 (de)	1989-03-24	1990-09-27	Behringwerke Ag	Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
DE4107154A1 (de) *	1990-10-11	1992-04-16	Boehringer Mannheim Gmbh	Monoklonale antikoerper gegen melanom
US6667156B2 (en) *	1995-12-27	2003-12-23	Uab Research Foundation	Diagnosis and treatment of neuroectodermal tumors
WO1997040140A1 (en) *	1996-04-22	1997-10-30	The Wistar Institute Of Anatomy And Biology	Gd2 anti-idiotypic antibodies and uses thereof
JP2011520914A (ja)	2008-05-15	2011-07-21	トランスモレキュラー，インコーポレイテッド	転移腫瘍の処置
JP5858932B2 (ja)	2010-02-04	2016-02-10	モルフォテック，インコーポレイテッド	クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
EP2569330B1 (en)	2010-05-11	2016-09-28	Fred Hutchinson Cancer Research Center	Chlorotoxin variants, conjugates, and methods for their use
EP2928913A1 (en)	2012-12-10	2015-10-14	Fred Hutchinson Cancer Research Center	Lipocalin fusion partners
US11559580B1 (en)	2013-09-17	2023-01-24	Blaze Bioscience, Inc.	Tissue-homing peptide conjugates and methods of use thereof
US12048732B2 (en)	2016-04-15	2024-07-30	Blaze Bioscience, Inc.	Methods of treating breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4675287A (en) *	1984-07-26	1987-06-23	Scripps Clinic And Research Foundation	Monoclonal antibody directed to human ganglioside GD2

1987
- 1987-09-18 AU AU80711/87A patent/AU617652B2/en not_active Ceased
- 1987-09-18 WO PCT/US1987/002419 patent/WO1988002117A1/en not_active Application Discontinuation
- 1987-09-18 EP EP19870906712 patent/EP0282581A4/en not_active Ceased
1988
- 1988-05-18 DK DK271488A patent/DK271488D0/da not_active Application Discontinuation
- 1988-05-18 FI FI882340A patent/FI882340L/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0282581A4 (en)	1988-11-02
AU8071187A (en)	1988-04-07
EP0282581A1 (en)	1988-09-21
WO1988002117A1 (en)	1988-03-24
FI882340L (fi)	1988-05-18
DK271488A (da)	1988-05-18
AU617652B2 (en)	1991-12-05
DK271488D0 (da)	1988-05-18

Publication	Publication Date	Title
FI881129A0 (fi)	1988-03-10	Skyddsmaterial och -foerfarande mot elektrisk oeverbelastning.
FI894135L (fi)	1989-09-01	Slangformig skyddsanordning foer skydd mot oeverfoering av smittande aemnen under koensumgaenge.
DE3774909D1 (de)	1992-01-16	Antitumormittel.
DE3767169D1 (de)	1991-02-14	Sportschuh.
ES2019949B3 (es)	1991-07-16	Propanaminas 3-ariloxi-3-sustituidas.
NO875113L (no)	1988-06-30	Transduser.
DE3764043D1 (de)	1990-09-06	Alkylendiamine.
FI874594L (fi)	1988-04-21	Mot oxidation stabiliserade laekemedelskompositioner.
FI874101L (fi)	1988-03-23	Tillsats foer belaeggningsbindemedel.
ATE63533T1 (de)	1991-06-15	Xylolisomerisierung.
FI871032L (fi)	1987-09-13	Svetsanordning foer med aendarna mot varandra kommande roerandar.
FI872507A0 (fi)	1987-06-04	Ljusbehandlingsbaedd.
DE3771918D1 (de)	1991-09-12	Chinolinamide.
NO871433D0 (no)	1987-04-06	Traadviklesystem.
DE3773636D1 (de)	1991-11-14	Saeurebeschleunigte hydrocarboxilierung.
FI882340L (fi)	1988-05-18	Paratropisk molekyl riktad mot human-gangliocid gd2.
FI871756L (fi)	1987-10-24	Skyddskrets foer skydd av en abonnentkrets mot oeverspaenningar.
DE3771271D1 (de)	1991-08-14	Fluorphthalimide.
FI885956L (fi)	1989-06-25	Monoklonaliska antikroppar mot lungkarcinom.
FI871757L (fi)	1987-10-24	Skyddskrets foer skydd av en abonnentkrets mot oeverspaenningar.
DE3763648D1 (de)	1990-08-16	Rollski.
DE3766410D1 (de)	1991-01-10	Methylalkylcyclosiloxane.
DE3669032D1 (de)	1990-03-22	Okulopressionsgeraet.
FI874508A0 (fi)	1987-10-13	Distributionsanordning.
DE3770459D1 (de)	1991-07-04	3-halogensuccinimide.

Legal Events

Date	Code	Title	Description
1993-03-30	FD	Application lapsed
2004-08-31	MM	Patent lapsed	Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION